INDP — Indaptus Therapeutics Share News
0.000.00%
Last trade - 00:00- $459.21m
- $447.65m
Brief: Intec Pharma And Decoy Biosystems Announce Merger Agreement
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:05 PM
U.S. RESEARCH ROUNDUP-Baker Hughes, Compass Minerals International, Intec pharma
U.S. STOCKS ON THE MOVE-Cybersecurity stocks, Boeing, Disney, Zoom
Intec Pharma: Hits two-month high on cannabinoid research deal
U.S. STOCKS ON THE MOVE-Cybersecurity stocks, Pluristem, Sorrento, GameStop
Brief: Intec Pharma Ltd Enters Into Feasibility Agreement With GW Research Limited, London, U.K
Brief: Intec Pharma Q3 Loss Per Share $0.95
Brief: Intec Pharma Announces 1-For-20 Reverse Share Split
U.S. STOCKS ON THE MOVE-Occidental Petroleum, Oxbridge Re Holdings, Roku, fuboTV, Beyond Meat
U.S. STOCKS ON THE MOVE-Corteva, Martin Marietta Materials, Tesla, Acuity Brands, Dana Inc
U.S. STOCKS ON THE MOVE-Medtronic, Carnival, JetBlue Airways, Bausch Health, Gilead, Cytokinetics
U.S. STOCKS ON THE MOVE-Eaton Vance, IBM, Domino's Pizza, Jazz Pharma, Moderna, American Airlines
Intec Pharma: Surges on research tie-up with Merck
Brief: Intec Pharma Announces New Research Collaboration Agreement With Msd
Brief: Intec Pharma Says Chief Medical Officer's Employment Would Be Terminated Effective As Of Oct. 31
Brief: Intec Pharma Announces Pricing Of $4.9 Million Registered Direct Offering
Brief: Intec Pharma Reports Q2 Loss Per Share $0.05
Brief: Intec Pharma Files Prelim Prospectus Related To Resale Of Aggregate Of Up To 8.1 Million Ordinary Shares By Selling Shareholders